Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.
PRINCIPEN '250' vs ACEPHEN
Clinician-reviewed, head-to-head comparison of mechanism, dosing, pharmacokinetics, and safety profiles.
Last clinically reviewed: July 2026 · OpiCalc Medical Review Team
Ampicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.
ACEPHEN (acetaminophen) is a para-aminophenol derivative with analgesic and antipyretic activity. Its mechanism involves inhibition of cyclooxygenase (COX) enzymes in the central nervous system, particularly COX-2, reducing prostaglandin synthesis. It has weak peripheral COX inhibition and minimal anti-inflammatory effect.
Infections caused by susceptible strains of Gram-positive and Gram-negative bacteria, including respiratory tract infections, urinary tract infections, meningitis, septicemia, and endocarditis,Off-label: Prophylaxis for bacterial endocarditis in dental procedures, treatment of listeriosis
Mild to moderate pain,Fever
250 mg orally every 6 hours
325-650 mg orally every 4-6 hours as needed; maximum 4 g/day.
1.0-1.5 hours in normal renal function; prolongation in renal impairment requires dose adjustment
Terminal elimination half-life: 1.0-1.5 hours in adults with normal renal function. Prolonged to 2-5 hours in hepatic impairment or elderly; requires dose adjustment in severe hepatic disease.
Ampicillin is primarily excreted unchanged by the kidneys via glomerular filtration and tubular secretion. Some hepatic metabolism occurs, but it is minimal.
Acetaminophen is primarily metabolized in the liver via glucuronidation (UGT1A1, UGT1A6, UGT1A9) and sulfation (SULT1A1, SULT1A3). A minor fraction is oxidized by cytochrome P450 enzymes (CYP2E1, CYP1A2, CYP3A4) to a reactive toxic metabolite (NAPQI), which is normally detoxified by conjugation with glutathione.
Primarily renal (60-80% unchanged), with some biliary/fecal excretion (approximately 10-20%)
Renal: 90-95% as unchanged drug; tubular secretion and glomerular filtration. Biliary/fecal: <5%.
20-25% bound to serum albumin
Approximately 10-20% bound to serum albumin; extensive tissue binding.
0.2-0.3 L/kg, indicating limited extravascular distribution
Apparent Vd: 0.5-0.7 L/kg (30-40 L in a 70 kg adult). Distributions into CSF and breast milk.
Oral: 25-40% (acid-labile, food reduces absorption)
Oral: 85-90% (first-pass metabolism minimal). Rectal: approximately 70-80% of oral bioavailability.
Cr Cl 10-50 m L/min: 250 mg every 12-24 hours; Cr Cl <10 m L/min: 250 mg every 24-48 hours
GFR 10-50 m L/min: 650 mg every 6 hours; GFR <10 m L/min: 650 mg every 8 hours.
No dosage adjustment required for mild to moderate hepatic impairment. Severe impairment (Child-Pugh C): reduce dose by 50% or extend interval to every 12 hours
Child-Pugh Class A: no adjustment; Child-Pugh Class B: maximum 2 g/day; Child-Pugh Class C: maximum 1 g/day.
Children >1 month: 12.5-25 mg/kg orally every 6 hours; maximum 4 g/day
10-15 mg/kg/dose orally every 4-6 hours; maximum 75 mg/kg/day or 4 g/day, whichever is less.
Monitor renal function; adjust dose based on Cr Cl as for adults with renal impairment. Avoid in elderly with Cr Cl <10 m L/min unless necessary.
Start at lowest effective dose (325 mg every 6 hours); avoid exceeding 3 g/day unless closely monitored.
No FDA black box warning.
Acetaminophen has been associated with cases of acute liver failure, at times resulting in liver transplant and death. Most of the cases of liver injury are associated with the use of acetaminophen at doses that exceed 4,000 milligrams per day, and often involve more than one acetaminophen-containing product.
Serious and occasionally fatal hypersensitivity reactions (anaphylaxis) have been reported; contraindicated in patients with penicillin allergy.,Clostridium difficile-associated diarrhea (CDAD) can occur and may range in severity from mild diarrhea to fatal colitis.,Prolonged use may result in overgrowth of nonsusceptible organisms, including fungi; superinfection may occur.,Use with caution in patients with renal impairment; dosage adjustment may be necessary.,Cases of drug-induced hepatitis and cholestatic jaundice have been reported.
Risk of severe liver injury with doses >4000 mg/day; use caution with hepatic impairment, chronic alcoholism, malnutrition, or concomitant hepatotoxic drugs; avoid exceeding recommended dose; limit use to 10 days for pain or 3 days for fever unless directed by physician; serious skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis) have occurred.
History of allergic reaction to any penicillin,Infections caused by penicillinase-producing organisms
Hypersensitivity to acetaminophen or any component of the formulation; severe hepatic impairment or active liver disease.
Food significantly reduces ampicillin absorption. Avoid taking with meals, dairy products, or acidic beverages (e.g., orange juice). Metal ions (calcium, iron, zinc) and antacids chelate ampicillin, reducing bioavailability. Alcohol does not directly interact but may increase risk of gastrointestinal upset.
Alcohol: increased risk of hepatotoxicity. Avoid concurrent use. Food: no significant interaction, but taking with food may reduce minor gastrointestinal irritation.
FDA Pregnancy Category B. Animal studies show no fetal risk, but no adequate human studies in first trimester. No known teratogenicity; use during pregnancy only if clearly needed.
Pregnancy Category C. First trimester: potential risk of neural tube defects and orofacial clefts (limited human data, animal studies show embryotoxicity). Second and third trimesters: NSAID exposure associated with oligohydramnios, premature ductus arteriosus constriction, and fetal renal impairment. Avoid in third trimester.
Ampicillin is excreted in breast milk in low concentrations. M/P ratio approximately 0.1-0.2. Considered compatible with breastfeeding by American Academy of Pediatrics; monitor infant for diarrhea and candidiasis.
Excreted into breast milk in low concentrations (M/P ratio approximately 0.10). Considered compatible with breastfeeding; however, use lowest effective dose for shortest duration given potential for neonatal adverse effects (e.g., thrombocytopenia, renal dysfunction).
Increased plasma volume and renal clearance during pregnancy may reduce serum ampicillin concentrations. No routine dose adjustment recommended, but for serious infections, doses at the higher end of the usual range may be considered. Monitor therapeutic response.
No standard dose adjustments recommended; however, due to increased plasma volume and metabolism in pregnancy, higher doses may be required to achieve therapeutic effect. Avoid near term.
Principen '250' (ampicillin) is a penicillinase-sensitive aminopenicillin with activity against Gram-positive cocci (except penicillinase-producing staphylococci) and some Gram-negative bacilli. Key pearls: (1) Administer on an empty stomach (1 hour before or 2 hours after meals) to enhance absorption; (2) Monitor for maculopapular rash, especially in patients with infectious mononucleosis or cytomegalovirus infection, where incidence approaches 70-100%; (3) Dose adjustment required in renal impairment (Cr Cl <30 m L/min); (4) Use caution in patients with history of hypersensitivity to penicillins or cephalosporins; (5) Not effective against penicillin-resistant Streptococcus pneumoniae; (6) Consider drug fever or serum sickness-like reactions as adverse effects.
ACEPHEN (acetaminophen) is commonly used for mild to moderate pain and fever. Avoid exceeding 4 g/day in adults to prevent hepatotoxicity. In patients with hepatic impairment, reduce maximum daily dose to 2 g. Consider acetylcysteine for overdose. Onset of action is 15-30 minutes orally.
Take this medication exactly as prescribed, at evenly spaced times, and finish the full course even if you feel better.,Take on an empty stomach, at least 1 hour before or 2 hours after meals, with a full glass of water.,Do not take with antacids, laxatives, or fruit juices, as they may reduce absorption.,Contact your doctor immediately if you develop a skin rash, hives, difficulty breathing, or swelling of the face, lips, or tongue.,Diarrhea is common; do not treat with anti-diarrhea medications without consulting your doctor, as it may indicate a more serious condition.,Inform your doctor if you are pregnant, breastfeeding, or have a history of kidney disease, asthma, or allergic reactions to any antibiotic.,This drug may reduce the effectiveness of oral contraceptives; use an additional barrier method during treatment.
Do not exceed 4000 mg (4 grams) in 24 hours.,Avoid drinking alcohol while taking this medication.,Do not combine with other products containing acetaminophen.,Take with food if stomach upset occurs.,Seek immediate medical help if you experience symptoms of liver damage: yellowing of skin/eyes, dark urine, severe abdominal pain.
No interactions on record
No interactions on record
Explore head-to-head clinical comparisons of other medications in the same therapeutic classes.
Common clinical questions about PRINCIPEN '250' vs ACEPHEN, answered by our medical review team.
PRINCIPEN '250' is a Aminopenicillin Antibiotic that works by Ampicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.. ACEPHEN is a Non-Opioid Analgesic that works by ACEPHEN (acetaminophen) is a para-aminophenol derivative with analgesic and antipyretic activity. Its mechanism involves inhibition of cyclooxygenase (COX) enzymes in the central nervous system, particularly COX-2, reducing prostaglandin synthesis. It has weak peripheral COX inhibition and minimal anti-inflammatory effect.. They differ in pharmacokinetic profiles, FDA-approved indications, and side effect profiles.
Potency comparisons between PRINCIPEN '250' and ACEPHEN depend on the specific clinical indication. These are agents from distinct pharmacological classes and are not directly interchangeable by dose. A physician or clinical pharmacist should guide any therapeutic switching decisions.
The standard adult dose of PRINCIPEN '250' is: 250 mg orally every 6 hours. The standard adult dose of ACEPHEN is: 325-650 mg orally every 4-6 hours as needed; maximum 4 g/day.. Dosing should always be individualized based on indication, renal and hepatic function, age, and other patient factors.
No direct drug-drug interaction has been formally documented between PRINCIPEN '250' and ACEPHEN in current clinical databases. However, individual patient risk factors including other medications, organ function, and comorbidities should always be evaluated by a qualified healthcare provider.
The maternal-fetal safety profiles differ. PRINCIPEN '250' is classified as Category C. FDA Pregnancy Category B. Animal studies show no fetal risk, but no adequate human studies in first trimester. No known teratogenicity; use during pregnancy only if clearly needed.. ACEPHEN is classified as Category C. Pregnancy Category C. First trimester: potential risk of neural tube defects and orofacial clefts (limited human data, animal studies show embryotoxicity). Second and third trimest. Always consult a maternal-fetal medicine specialist before taking either drug during pregnancy or lactation.